Clients Making Headlines: Diplomat Pharmacy Launches IPO

Congrats to Phil Hagerman, CEO, and the rest of the team! 

Diplomat Pharmacy is now the nation’s largest specialty pharmaceutical company.   The company serves about one percent of the nation’s sickest patients by providing drugs for complex treatments for cancer, Crohn’s disease and other illnesses. 

Diplomat started trading its stock publicly on on 10/10/14.

To read the entire article, please visit